Net Income (Loss) Per Share

6 Months Ended

Jun. 30, 2023

A reconciliation of net income (loss) available to common shareholders and the number of shares in the calculation of basic and diluted earnings (loss) per share was calculated as follows:


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
(in thousands, except for share and per share amounts)	2023		2022		2023		2022
Net income (loss) attributable to Privia Health Group, Inc. common stockholders	$	7,274	$	(10,475)	$	14,598	$	(27,985)
Weighted average common shares outstanding - basic	116,161,251		108,685,835		115,588,313		108,374,181
Weighted average common share outstanding - diluted	124,570,875		108,685,835		124,467,343		108,374,181
Earnings (loss) per share attributable to Privia Health Group, Inc. common stockholders – basic	$	0.06	$	(0.10)	$	0.13	$	(0.26)
Earnings (loss) per share attributable to Privia Health Group, Inc. common stockholders – diluted	$	0.06	$	(0.10)	$	0.12	$	(0.26)

The treasury stock method is used to consider the effect of the potentially dilutive stock options. The following outstanding shares of potentially dilutive securities were excluded from computation of diluted loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:


	Six Months Ended June 30,
	2023	2022
Potentially dilutive stock options to purchase common stock, RSUs and PSUs	6,013,289	20,195,513
Total potentially dilutive shares	6,013,289	20,195,513